These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 3012662

  • 1. [Magnetic resonance in the study of cerebral gliomas].
    Vaghi MA, Visciani A, Passerini A, Longone V, Broggi G.
    Radiol Med; 1986 Jun; 72(6):431-8. PubMed ID: 3012662
    [Abstract] [Full Text] [Related]

  • 2. MR imaging in cerebral gliomas. Tissue component analysis in correlation with histopathology of whole-brain specimens.
    Tovi M, Hartman M, Lilja A, Ericsson A.
    Acta Radiol; 1994 Sep; 35(5):495-505. PubMed ID: 8086262
    [Abstract] [Full Text] [Related]

  • 3. High-grade and low-grade gliomas: differentiation by using perfusion MR imaging.
    Hakyemez B, Erdogan C, Ercan I, Ergin N, Uysal S, Atahan S.
    Clin Radiol; 2005 Apr; 60(4):493-502. PubMed ID: 15767107
    [Abstract] [Full Text] [Related]

  • 4. Low-grade glioma on stereotactic biopsy: how often is the diagnosis accurate?
    Muragaki Y, Chernov M, Maruyama T, Ochiai T, Taira T, Kubo O, Nakamura R, Iseki H, Hori T, Takakura K.
    Minim Invasive Neurosurg; 2008 Oct; 51(5):275-9. PubMed ID: 18855292
    [Abstract] [Full Text] [Related]

  • 5. The use of proton MRS in the differential diagnosis of brain tumors and tumor-like processes.
    Gajewicz W, Papierz W, Szymczak W, Goraj B.
    Med Sci Monit; 2003 Sep; 9(9):MT97-105. PubMed ID: 12960934
    [Abstract] [Full Text] [Related]

  • 6. [Contrast medium assisted nuclear magnetic resonance tomography. Signal intensity of gliomatous tumors].
    Agnoli AL, Herrmann S.
    Rontgenblatter; 1990 Aug; 43(8):335-40. PubMed ID: 2399417
    [Abstract] [Full Text] [Related]

  • 7. Can the apparent diffusion coefficient be used as a noninvasive parameter to distinguish tumor tissue from peritumoral tissue in cerebral gliomas?
    Pauleit D, Langen KJ, Floeth F, Hautzel H, Riemenschneider MJ, Reifenberger G, Shah NJ, Müller HW.
    J Magn Reson Imaging; 2004 Nov; 20(5):758-64. PubMed ID: 15503327
    [Abstract] [Full Text] [Related]

  • 8. Proton magnetic resonance spectroscopy of brain tumors correlated with pathology.
    Magalhaes A, Godfrey W, Shen Y, Hu J, Smith W.
    Acad Radiol; 2005 Jan; 12(1):51-7. PubMed ID: 15691725
    [Abstract] [Full Text] [Related]

  • 9. Quantitative assessment of gliomas by proton magnetic resonance spectroscopy.
    Oshiro S, Tsugu H, Komatsu F, Abe H, Onishi H, Ohmura T, Iwaasa M, Sakamoto S, Fukushima T.
    Anticancer Res; 2007 Jan; 27(6A):3757-63. PubMed ID: 17970039
    [Abstract] [Full Text] [Related]

  • 10. Stereotactic biopsy in gliomas guided by 3-tesla 1H-chemical-shift imaging of choline.
    Hermann EJ, Hattingen E, Krauss JK, Marquardt G, Pilatus U, Franz K, Setzer M, Gasser T, Tews DS, Zanella FE, Seifert V, Lanfermann H.
    Stereotact Funct Neurosurg; 2008 Jan; 86(5):300-7. PubMed ID: 18791331
    [Abstract] [Full Text] [Related]

  • 11. Stereotactic guided laser-induced interstitial thermotherapy (SLITT) in gliomas with intraoperative morphologic monitoring in an open MR: clinical expierence.
    Leonardi MA, Lumenta CB.
    Minim Invasive Neurosurg; 2002 Dec; 45(4):201-7. PubMed ID: 12494354
    [Abstract] [Full Text] [Related]

  • 12. [Role of magnetic resonance in the follow-up o hepatocarcinoma treated with percutaneous ethanol injection (PEI) or transarterial chemoembolization (TACE)].
    De Cobelli F, Castrucci M, Sironi S, Livraghi T, Venturini M, Salvioni M, Del Maschio A.
    Radiol Med; 1994 Dec; 88(6):806-17. PubMed ID: 7878241
    [Abstract] [Full Text] [Related]

  • 13. [A clinicopathological study of nine cases of midbrain glioma].
    Nitta T, Sato K.
    No Shinkei Geka; 1995 May; 23(5):405-10. PubMed ID: 7753319
    [Abstract] [Full Text] [Related]

  • 14. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.
    Fayed N, Dávila J, Medrano J, Olmos S.
    Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889
    [Abstract] [Full Text] [Related]

  • 15. Perfusion magnetic resonance imaging predicts patient outcome as an adjunct to histopathology: a second reference standard in the surgical and nonsurgical treatment of low-grade gliomas.
    Law M, Oh S, Johnson G, Babb JS, Zagzag D, Golfinos J, Kelly PJ.
    Neurosurgery; 2006 Jun; 58(6):1099-107; discussion 1099-107. PubMed ID: 16723889
    [Abstract] [Full Text] [Related]

  • 16. Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema.
    Server A, Kulle B, Maehlen J, Josefsen R, Schellhorn T, Kumar T, Langberg CW, Nakstad PH.
    Acta Radiol; 2009 Jul; 50(6):682-9. PubMed ID: 19449234
    [Abstract] [Full Text] [Related]

  • 17. [Image guided stereotactic biopsy for brain tumors: experience of 71 cases].
    Matsumoto K, Tomita S, Higashi H, Nakagawa M, Adachi H, Tada E, Maeda Y, Ohmoto T.
    No Shinkei Geka; 1995 Oct; 23(10):897-903. PubMed ID: 7477699
    [Abstract] [Full Text] [Related]

  • 18. [Correlation between magnetic resonance diffusion weighted imaging and cell density in astrocytoma].
    Chen J, Xia J, Zhou YC, Xia LM, Zhu WZ, Zou ML, Feng DY, Wang CY.
    Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):309-11. PubMed ID: 15996330
    [Abstract] [Full Text] [Related]

  • 19. [On the slow evolution of certain gliomas of the brain].
    Ravenna C.
    Riv Patol Nerv Ment; 1967 May; 88(2):169-87. PubMed ID: 5621268
    [No Abstract] [Full Text] [Related]

  • 20. [T2-analysis of normal and pathological structures of the head].
    Skalej M, Higer HP, Meves M, Brückner A, Bielke G, Meindl S, Rinck PA, Pfannenstiel P.
    Digitale Bilddiagn; 1985 Sep; 5(3):112-9. PubMed ID: 2996822
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.